Dare Bioscience (NASDAQ:DARE) will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Dare Bioscience to report an earnings per share (EPS) of $-0.63.

Anticipation surrounds Dare Bioscience's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

During the last quarter, the company reported an EPS beat by $0.16, leading to a 9.96% drop in the share price on the subsequent day.

Here's a look at Dare Bioscience's past performance and the resulting price change:

Market Performance of Dare Bioscience's Stock

Shares of Dare Bioscience were trading at $2.89 as of March 27. Over the last 52-week period, shares are down 50.45%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Dare Bioscience visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.